These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1316540)

  • 1. Amino acid substitutions in the DNA-binding domain of the human androgen receptor are a frequent cause of receptor-binding positive androgen resistance.
    Zoppi S; Marcelli M; Deslypere JP; Griffin JE; Wilson JD; McPhaul MJ
    Mol Endocrinol; 1992 Mar; 6(3):409-15. PubMed ID: 1316540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human androgen insensitivity due to point mutations encoding amino acid substitutions in the androgen receptor steroid-binding domain.
    Murono K; Mendonca BB; Arnhold IJ; Rigon AC; Migeon CJ; Brown TR
    Hum Mutat; 1995; 6(2):152-62. PubMed ID: 7581399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutation in the DNA-binding domain of the androgen receptor gene causes complete testicular feminization in a patient with receptor-positive androgen resistance.
    Marcelli M; Zoppi S; Grino PB; Griffin JE; Wilson JD; McPhaul MJ
    J Clin Invest; 1991 Mar; 87(3):1123-6. PubMed ID: 1999491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen resistance associated with a mutation of the androgen receptor at amino acid 772 (Arg----Cys) results from a combination of decreased messenger ribonucleic acid levels and impairment of receptor function.
    Marcelli M; Tilley WD; Zoppi S; Griffin JE; Wilson JD; McPhaul MJ
    J Clin Endocrinol Metab; 1991 Aug; 73(2):318-25. PubMed ID: 1856263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A frame-shift mutation of the androgen receptor gene in a patient with receptor-negative complete testicular feminization: comparison with a single base substitution in a receptor-reduced incomplete form.
    Imai A; Ohno T; Iida K; Ohsuye K; Okano Y; Tamaya T
    Ann Clin Biochem; 1995 Sep; 32 ( Pt 5)():482-6. PubMed ID: 8830623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definition of the human androgen receptor gene structure permits the identification of mutations that cause androgen resistance: premature termination of the receptor protein at amino acid residue 588 causes complete androgen resistance.
    Marcelli M; Tilley WD; Wilson CM; Griffin JE; Wilson JD; McPhaul MJ
    Mol Endocrinol; 1990 Aug; 4(8):1105-16. PubMed ID: 2293020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid substitutions in the hormone-binding domain of the human androgen receptor alter the stability of the hormone receptor complex.
    Marcelli M; Zoppi S; Wilson CM; Griffin JE; McPhaul MJ
    J Clin Invest; 1994 Oct; 94(4):1642-50. PubMed ID: 7929841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic basis of endocrine disease. 4. The spectrum of mutations in the androgen receptor gene that causes androgen resistance.
    McPhaul MJ; Marcelli M; Zoppi S; Griffin JE; Wilson JD
    J Clin Endocrinol Metab; 1993 Jan; 76(1):17-23. PubMed ID: 8421085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel substitution (Leu707Arg) in exon 4 of the androgen receptor gene causes complete androgen resistance.
    Lumbroso S; Lobaccaro JM; Georget V; Leger J; Poujol N; Térouanne B; Evain-Brion D; Czernichow P; Sultan C
    J Clin Endocrinol Metab; 1996 May; 81(5):1984-8. PubMed ID: 8626869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial androgen insensitivity caused by an androgen receptor mutation at amino acid 907 (Gly-->Arg) that results in decreased ligand binding affinity and reduced androgen receptor messenger ribonucleic acid levels.
    Choong CS; Sturm MJ; Strophair JA; McCulloch RK; Tilley WD; Leedman PJ; Hurley DM
    J Clin Endocrinol Metab; 1996 Jan; 81(1):236-43. PubMed ID: 8550758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A G577R mutation in the human AR P box results in selective decreases in DNA binding and in partial androgen insensitivity syndrome.
    Nguyen D; Steinberg SV; Rouault E; Chagnon S; Gottlieb B; Pinsky L; Trifiro M; Mader S
    Mol Endocrinol; 2001 Oct; 15(10):1790-802. PubMed ID: 11579211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A point mutation in the second zinc finger of the DNA-binding domain of the androgen receptor gene causes complete androgen insensitivity in two siblings with receptor-positive androgen resistance.
    Mowszowicz I; Lee HJ; Chen HT; Mestayer C; Portois MC; Cabrol S; Mauvais-Jarvis P; Chang C
    Mol Endocrinol; 1993 Jul; 7(7):861-9. PubMed ID: 8413310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two de novo mutations in the AR gene cause the complete androgen insensitivity syndrome in a pair of monozygotic twins.
    Mongan NP; Jääskeläinen J; Green K; Schwabe JW; Shimura N; Dattani M; Hughes IA
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1057-61. PubMed ID: 11889162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete testicular feminization caused by an amino-terminal truncation of the androgen receptor with downstream initiation.
    Zoppi S; Wilson CM; Harbison MD; Griffin JE; Wilson JD; McPhaul MJ; Marcelli M
    J Clin Invest; 1993 Mar; 91(3):1105-12. PubMed ID: 8450040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single nucleotide substitution introduces a premature termination codon into the androgen receptor gene of a patient with receptor-negative androgen resistance.
    Marcelli M; Tilley WD; Wilson CM; Wilson JD; Griffin JE; McPhaul MJ
    J Clin Invest; 1990 May; 85(5):1522-8. PubMed ID: 2332504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single amino acid substitution (gly743 --> val) in the steroid-binding domain of the human androgen receptor leads to Reifenstein syndrome.
    Nakao R; Yanase T; Sakai Y; Haji M; Nawata H
    J Clin Endocrinol Metab; 1993 Jul; 77(1):103-7. PubMed ID: 8325932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substitution of valine-865 by methionine or leucine in the human androgen receptor causes complete or partial androgen insensitivity, respectively with distinct androgen receptor phenotypes.
    Kazemi-Esfarjani P; Beitel LK; Trifiro M; Kaufman M; Rennie P; Sheppard P; Matusik R; Pinsky L
    Mol Endocrinol; 1993 Jan; 7(1):37-46. PubMed ID: 8446106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant measures of androgen-binding kinetics in two mutant androgen receptors causing mild or partial androgen insensitivity, respectively.
    Shkolny DL; Beitel LK; Ginsberg J; Pekeles G; Arbour L; Pinsky L; Trifiro MA
    J Clin Endocrinol Metab; 1999 Feb; 84(2):805-10. PubMed ID: 10022458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel androgen receptor gene mutations in Australian patients with complete androgen insensitivity syndrome.
    MacLean HE; Ball EM; Rekaris G; Warne GL; Zajac JD
    Hum Mutat; 2004 Mar; 23(3):287. PubMed ID: 14974091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single base mutations in the human androgen receptor gene causing complete androgen insensitivity: rapid detection by a modified denaturing gradient gel electrophoresis technique.
    De Bellis A; Quigley CA; Cariello NF; el-Awady MK; Sar M; Lane MV; Wilson EM; French FS
    Mol Endocrinol; 1992 Nov; 6(11):1909-20. PubMed ID: 1480178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.